ReShape Lifesciences Inc. Stock Other OTC
Equities
RSLS
US7611236032
Advanced Medical Equipment & Technology
Financials (USD)
Sales 2024 * | 9.99M | Sales 2025 * | 11.99M | Capitalization | 4M |
---|---|---|---|---|---|
Net income 2024 * | -6M | Net income 2025 * | -5M | EV / Sales 2024 * | 0.4 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.33 x |
P/E ratio 2024 * |
-0.38
x | P/E ratio 2025 * |
-0.47
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.84% |
Latest transcript on ReShape Lifesciences Inc.
Managers | Title | Age | Since |
---|---|---|---|
Paul Hickey
CEO | Chief Executive Officer | 59 | 20-01-31 |
Director of Finance/CFO | 63 | 21-06-14 | |
Dov Gal
CMP | Compliance Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Gary Blackford
BRD | Director/Board Member | 66 | 15-12-31 |
Dan Gladney
CHM | Chairman | 70 | 15-10-31 |
Director/Board Member | 70 | 21-06-14 |
1st Jan change | Capi. | |
---|---|---|
+2.02% | 207B | |
+2.17% | 175B | |
+10.45% | 132B | |
+16.62% | 99.1B | |
-3.69% | 60.89B | |
+13.38% | 52.04B | |
-6.33% | 45.48B | |
-4.74% | 38.81B | |
+9.89% | 38.77B |